Phase angle as a potential tool to evaluate chronic inflammatory state and predict quality of life deterioration in women with breast cancer and obesity: A narrative review.
Fernanda Sarahí Fajardo-EspinozaSara Aileen Cabrera-NietoAna Lorena Espada-VargasDana Aline Pérez-CamargoAlejandro MoharMarlid Cruz-RamosPublished in: Nutrition (Burbank, Los Angeles County, Calif.) (2024)
The interaction between lifestyle--defined more specifically in health care as the personal exposome--and its implications on obesity and breast cancer development highlights the critical role of body composition and inflammation in these patients. There is clear evidence that the personal and internal exposome triggers biochemical, inflammatory, and metabolic reprogramming, which might favor ectopic lipid accumulation within the body, such as muscles. Additionally, the presence of excessive adipose tissue exacerbates these alterations in the internal exposome, resulting in cell damage and modifying body composition. Understanding the nexus between these lifestyle-induced exposome modifications, such as inflammation, and the resultant changes in body composition is crucial to assess the association with breast cancer progression and treatment responses. Various techniques can be used to evaluate body composition; one of those most used currently is bioelectrical impedance analysis. This analysis provides parameters, including phase angle (PhA), by which cellular health and metabolic activity can be assessed. In addition, PhA is a potential indicator of nutritional status and disease prognosis, as it has been linked to survival and quality of life in patients with cancer. Therefore, PhA might be used in daily oncology practice to implement an accurate nutritional intervention, reducing side effects and complications of oncology management, and improving quality of life during treatment and survival, even in patients with breast cancer with obesity or overweight. The aim of this review is to analyze the existing information on the current application of PhA in patients with breast cancer and its potential use as a tool to assess inflammatory response, identify malnutrition, and predict the deterioration of quality of life so that it could be proposed as an early indicator for nutritional interventions in this group of patients.
Keyphrases
- body composition
- resistance training
- bone mineral density
- weight loss
- metabolic syndrome
- healthcare
- oxidative stress
- end stage renal disease
- insulin resistance
- physical activity
- weight gain
- inflammatory response
- adipose tissue
- type diabetes
- ejection fraction
- newly diagnosed
- chronic kidney disease
- randomized controlled trial
- peritoneal dialysis
- high resolution
- primary care
- prognostic factors
- single cell
- cardiovascular disease
- high fat diet
- stem cells
- toll like receptor
- computed tomography
- drug induced
- endothelial cells
- patient reported
- mesenchymal stem cells
- social media
- high glucose
- replacement therapy
- contrast enhanced
- breast cancer risk